Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Body Mass Index and Outcomes in Acute Myeloid Leukemia

Daniel R Reed, MD, John Wang, Ramey Elsarrag, MS/MD, Krista M. Isaac, MD, Michael K Keng, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-143184

Published: 2020

Journal Articles

Distance Does Not Matter: Excellent Survival Outcomes for Leukemia Patients in Rural Appalachia

Krista Isaac, DO,MS, Daniel R Reed, MD, Raj Piyush Desai, MS, Eli Williams, PhD, Rajesh Balkrishnan, PhD, Michael K Keng, MD, Karen K. Ballen, MD

Blood (2019) 134 (Supplement_1): 4784.

https://doi.org/10.1182/blood-2019-125829

Published: 2019

Journal Articles

Planned Interim Analysis of a Phase 2 Study Evaluating the Combination of Pracinostat, a Histone Deacetylase Inhibitor (HDACi), and Azacitidine in Patients with High/Very High-Risk Myelodysplastic Syndrome (MDS)

Michael K Keng, MD, Samer K. Khaled, MD, Brenda Cooper, MD, Erica D. Warlick, MD, David Ramies, MD, Silvia Mappa, MD, Ehab L. Atallah, MD

Blood (2018) 132 (Supplement 1): 4362.

https://doi.org/10.1182/blood-2018-99-112741

Published: 2018

Journal Articles

Venous Thromboembolism Events and Prophylaxis in Patients with Acute Myeloid Leukemia

Daniel R Reed, MD, Maria C Nicolais, MD, Victor M. Orellana-Noia, MD, Samantha J Minkin, MD, Amy L Morris, PharmD, Hillary S. Maitland, MD MS, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 5066.

https://doi.org/10.1182/blood-2018-99-112507

Published: 2018

Journal Articles

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Daniel R Reed, MD, Katie E Ruefer, RN, Tanya D Thomas, RN, Erin L Harr, RN, Elizabeth R Daniels, RN, Jeremy M Sen, PharmD, BCOP, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2018-99-112598

Published: 2018

Journal Articles

Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate

Daniel R Reed, MD, Jeremy M Sen, PharmD, BCOP, Eric J Pierce, MD, Maria C Nicolais, MD, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 2309.

https://doi.org/10.1182/blood-2018-99-112606

Published: 2018

Journal Articles

Novel Risk Factors for Predicting the Development of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Undergoing Induction and Re-Induction Chemotherapy

Mohammed Athar Naeem, MD PhD, Amy L Morris, PharmD, Mark Smolkin, MS, Torrey Murray, RN, BSN, PCCN, Jessica D Lewis, MD, Kathlene DeGregory, PharmD, BCOP, Tanya Thomas, RN, Anjali Bal, MD, Michael K. Keng, MD

Blood (2016) 128 (22): 5165.

https://doi.org/10.1182/blood.V128.22.5165.5165

Published: 2016

Journal Articles

Clostridium Difficile Infection in Patients with Acute Myeloid Leukemia

Amy L Morris, PharmD, Mohammed Athar Naeem, MD PhD, Anjali Bal, MD, Tanya Thomas, RN, Alfadel Alshaibani, MD, Bethany Horton, PhD, Michael K. Keng, MD

Blood (2016) 128 (22): 5181.

https://doi.org/10.1182/blood.V128.22.5181.5181

Published: 2016

Journal Articles

Distinct Pattern Of Genomic Changes Associated With Smoking In Patients With Myelodysplastic Syndromes (MDS)

David J. Seastone, DO, PhD, Sudipto Mukherjee, MD, PhD, MPH, Zaher K. Otrock, MD, Paul Elson, ScD, Michael K. Keng, MD, Bartlomiej Przychodzen, Ph.D., Hideki Makishima, MD, PhD, Brittney Dienes, Sean Hobson, Kristin Dodd, RN, Tracy Cinalli, RN, Ramon V Tiu, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS

Blood (2013) 122 (21): 660.

https://doi.org/10.1182/blood.V122.21.660.660

Published: 2013

Journal Articles

The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)

Aziz Nazha, MD, Sudipto Mukherjee, MD, PhD, MPH, Ramon V. Tiu, MD, Yogen Saunthararajah, MD, Michael K. Keng, MD, David J. Seastone, DO, PhD, Sean Hobson, Anjali S. Advani, MD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS

Blood (2013) 122 (21): 1524.

https://doi.org/10.1182/blood.V122.21.1524.1524

Published: 2013

Journal Articles

The Degree and Effect Of Weight Loss In Acute Myeloid Leukemia Patients Receiving Induction and Post-Remission Chemotherapy

Michael K. Keng, MD, Surbhi Sidana, MD, Sudipto Mukherjee, MD, PhD, MPH, Paul Elson, ScD, David J. Seastone, DO, PhD, Aziz Nazha, MD, Amanda L. Maggiotto, BS, CCRP, Madeline J. Schaub, BS, Candice M. Wenzell, PharmD, BCOP, Anjali S. Advani, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD, MS

Blood (2013) 122 (21): 3889.

https://doi.org/10.1182/blood.V122.21.3889.3889

Published: 2013

Journal Articles

Prospective Study Of An Emergency Department Febrile Neutropenia Pathway In Patients With Hematologic Malignancies

Michael K. Keng, MD, Elaine Thallner, MD, MS, Paul Elson, ScD, Christine Zayac, MA, Jennifer Sekeres, PharmD, BCPS, Candice M. Wenzell, PharmD, BCOP, Erika M. Gallagher, PharmD, BCOP, Catherine M. Weber, PharmD, BCOP, Marc A. Earl, PharmD, BCOP, Sudipto Mukherjee, MD, PhD, MPH, David J. Seastone, DO, PhD, Brad Pohlman, MD, Eric Cober, MD, Beth Rodgers, RN, MSN, CEN, Virginia B. Foster, PhD, MPH, Joy Yuhas, RN, MSN, Matt Kalaycio, MD, Brian J. Bolwell, MD, Mikkael A. Sekeres, MD, MS

Blood (2013) 122 (21): 556.

https://doi.org/10.1182/blood.V122.21.556.556

Published: 2013

Journal Articles

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Moshe Ornstein, MD, MA, Sudipto Mukherjee, MD PhD, Michael K. Keng, MD, Paul Elson, ScD, Ramon V. Tiu, MD, Yogenthiran Saunthararajah, MD, Leslie Farhat, Diane Banks, Anjali Advani, MD, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS

Blood (2012) 120 (21): 1487.

https://doi.org/10.1182/blood.V120.21.1487.1487

Published: 2012

NARROW

Body Mass Index and Outcomes in Acute Myeloid Leukemia

Distance Does Not Matter: Excellent Survival Outcomes for Leukemia Patients in Rural Appalachia

Planned Interim Analysis of a Phase 2 Study Evaluating the Combination of Pracinostat, a Histone Deacetylase Inhibitor (HDACi), and Azacitidine in Patients with High/Very High-Risk Myelodysplastic Syndrome (MDS)

Venous Thromboembolism Events and Prophylaxis in Patients with Acute Myeloid Leukemia

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate

Novel Risk Factors for Predicting the Development of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Undergoing Induction and Re-Induction Chemotherapy

Clostridium Difficile Infection in Patients with Acute Myeloid Leukemia

Distinct Pattern Of Genomic Changes Associated With Smoking In Patients With Myelodysplastic Syndromes (MDS)

The Revised International Prognostic Scoring System (IPSS-R) Is Not Predictive Of Survival In Patients With Secondary Myelodysplastic Syndromes (MDS)

The Degree and Effect Of Weight Loss In Acute Myeloid Leukemia Patients Receiving Induction and Post-Remission Chemotherapy

Prospective Study Of An Emergency Department Febrile Neutropenia Pathway In Patients With Hematologic Malignancies

Vancomycin-Resistant Enterococcus (VRE) Bacteremia During Acute Myeloid Leukemia (AML) Induction Therapy Is an Independent Predictor of Poor Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only